Pharmacyte Biotech Inc (PMCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 01-2022 | 10-2021 | 07-2021 | 04-2021 | 01-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 86,640 | 86,939 | 959 | 2,202 | 3,091 |
| TOTAL | $86,814 | $87,180 | $1,508 | $2,275 | $3,133 |
| Non-Current Assets | |||||
| Investments And Advances | 1,572 | 1,572 | 1,572 | 1,572 | 1,572 |
| Intangibles | 3,549 | 3,549 | 3,549 | 3,549 | 3,549 |
| Other Non-Current Assets | 8 | 8 | 7 | 7 | 7 |
| TOTAL | $5,129 | $5,129 | $5,129 | $5,129 | $5,129 |
| Total Assets | $91,943 | $92,310 | $6,637 | $7,404 | $8,262 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 67 |
| Accounts payable and accrued liabilities | 93 | 157 | 395 | 172 | 79 |
| Accrued Expenses | 520 | 29 | 530 | 553 | 494 |
| TOTAL | $613 | $186 | $925 | $725 | $640 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 8 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $8 |
| Total Liabilities | $613 | $186 | $925 | $725 | $649 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 20,721 | 20,716 | 20,715 | 1,612 | 1,670 |
| Common Shares | 2 | 2 | 0 | 0 | 234 |
| Retained earnings | -110,226 | -109,415 | -108,435 | -107,410 | -106,450 |
| Other shareholders' equity | -19 | -19 | -22 | -20 | -21 |
| TOTAL | $91,330 | $92,124 | $5,712 | $6,680 | $7,613 |
| Total Liabilities And Equity | $91,943 | $92,310 | $6,637 | $7,404 | $8,262 |